Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
about
Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as ExamplesTrends of hospitalizations, fatality rate and costs for acute myocardial infarction among Spanish diabetic adults, 2001-2006Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.Egg consumption and risk of type 2 diabetes in older adults.Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitusThe prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims databaseImpact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.Economic burden of hepatitis B infection among patients with diabetes.Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions.Resource use associated with type 2 diabetes in Africa, the Middle East, South Asia, Eurasia and Turkey: results from the International Diabetes Management Practice Study (IDMPS).Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis.
P2860
Q26774170-E14FB285-A3D5-499C-BAAE-AFBF5B389C2CQ33537505-28A122CE-3C12-4137-A649-EC6C5B45058EQ33652884-CD2F27C3-9909-404D-91C1-80D0625893F2Q33994349-F4604CD2-61CD-4948-A1E0-46BBAD16A7E1Q34024171-33ED80A8-4761-44B9-BE99-A5B6D0212D59Q34550144-B08E9479-A888-4138-A2A5-A0DBDCCE3752Q36445913-4D071167-4720-4EFF-8A5F-407777824B84Q37131065-C531EE36-6475-43E2-BC62-15E09F018955Q37437079-B4E3C7E2-53B7-4D5E-B096-38EF20D320EBQ37598023-681C9106-F9EC-4373-B2F0-3DC5FE3E0398Q55054491-5B007290-B4A2-4A17-98B9-1B8AA05D4FCA
P2860
Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Total and component health car ...... without macrovascular disease.
@en
Total and component health car ...... without macrovascular disease.
@nl
type
label
Total and component health car ...... without macrovascular disease.
@en
Total and component health car ...... without macrovascular disease.
@nl
prefLabel
Total and component health car ...... without macrovascular disease.
@en
Total and component health car ...... without macrovascular disease.
@nl
P2093
P1476
Total and component health car ...... without macrovascular disease.
@en
P2093
Bhash M Parasuraman
Jerry L Wall
Justin J Sherman
Lesa W Lawrence
Robert M Darin
Shravanthi R Gandra
P304
P356
10.18553/JMCP.2006.12.7.546
P577
2006-09-01T00:00:00Z